Sun Pharmaceutical Industries Shows Short-Term Gains Amid Mixed Long-Term Trends
Sun Pharmaceutical Industries has demonstrated strong performance today, outperforming its sector. The stock has gained over three consecutive days, maintaining its opening price. While currently above its 5-day moving average, it remains below longer-term averages. The company has a market cap of Rs 3,89,172.00 crore and a P/E ratio of 33.93.
Sun Pharmaceutical Industries has shown notable activity today, outperforming its sector by 0.55%. The stock has been on a positive trajectory, gaining for three consecutive days with a total return of 3.21% during this period. It opened at Rs 1,637.6 and has maintained this price throughout the trading session.In terms of moving averages, the stock is currently above its 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a mixed short-term performance relative to longer-term trends.
The company operates within the Pharmaceuticals & Biotechnology industry, boasting a market capitalization of Rs 3,89,172.00 crore. Its price-to-earnings (P/E) ratio stands at 33.93, slightly below the industry average of 34.85.
Over the past year, Sun Pharmaceutical Industries has experienced a decline of 6.63%, contrasting with the Sensex's gain of 2.02%. However, its long-term performance remains robust, with a 5-year increase of 211.43%, significantly outperforming the Sensex's 110.26% over the same period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
